By Dr William Brooks

Journal articles

Waite LM; Creasey H; Grayson DA; Edelbrock D; Cullen J; Brooks WS; Casey B; Bennett HP; Broe T, 2001, 'Clinical diagnosis and disability among community dwellers aged 75 and over: The Sydney older persons study.', Australasian Journal on Ageing, 20, pp. 67 - 72

Stanford PM; Halliday GM; Brooks WS; Kwok JB; Schofield PR, 2001, 'Progressive supranuclear palsy, frontotemporal dementia with parkinsonism linked to chromosome 17 and familial tauopathies.', Brain, 124, pp. 1668 - 1670

Kwok JB; Mclean C; Kril J; Broe T; Nicholson GA; Cappai R; Hallupp M; Cotton R; Schofield PR; Brooks WS; Smith MJ, 2001, 'Variable phenotypes of Alzheimer`s disease with spastic paraparesis', Annals of Neurology, pp. 125 - 129

Milward E; Grayson D; Creasey H; Kyngdon B; Janu M; Brooks W; Broe GA, 2000, 'Clinical issues - Anaemia and dementia in community-dwelling Australian elderly', AUSTRALASIAN JOURNAL ON AGEING, 19, pp. 25 - 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086449500094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Broe T; Grayson DA; Creasey H; Waite LM; Casey B; Bennett HP; Brooks WS; Halliday GM, 2000, 'Anti-inflammatory drugs protect against Alzheimer's disease at low doses', Archives of Neurology, pp. 1586 - 1591

Stanford PM; Halliday GM; Brooks WS; Kwok JB; Storey CE; Creasey H; Morris J; Fulham MJ; Schofield PR, 2000, 'Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene. Expansion of the disease phenotype caused by tau gene mutations', Brain, 123, pp. 880 - 893

Stanford PM; Halliday GM; Brooks WS; Kwok JB; Storey CE; Creasey H; Morris JG; Fulham MJ, 2000, 'Tau gene mutations are pleiotropic: Identification of two novel mutations in the tau gene', Neurobiology of Aging, 21, pp. 36 - 36, http://dx.doi.org/10.1016/s0197-4580(00)82837-7

Kwok JBJ; Smith MJ; Brooks WS; Kril J; Mclean C; Hallupp M; Schofield PR, 2000, 'Variable presentation of Alzheimer's disease and/or spastic paraparesis phenotypes in pedigrees with a novel PS-1 exon 9 gene deletion or exon 9 splice acceptor mutations', Neurobiology of Aging, 21, pp. 25 - 25, http://dx.doi.org/10.1016/s0197-4580(00)82789-x

Milward EA; Grayson DA; Creasey H; Janu MR; Brooks WS; Broe GA, 1999, 'Evidence for association of anaemia with vascular dementia', NeuroReport, 10, pp. 2377 - 2381, http://dx.doi.org/10.1097/00001756-199908020-00029

Laws SM; Taddei K; Martins G; Paton A; Fisher C; Clarnette R; Hallmayer J; Brooks WS; Gandy SE; Martins RN, 1999, 'The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease', NeuroReport, 10, pp. 879 - 882, http://dx.doi.org/10.1097/00001756-199903170-00038

Laws SM; Taddei K; Fisher C; Small D; Clarnette R; Hallmayer J; Brooks WS; Kwok JB; Schofield PR; Gandy SE; Martins RN, 1999, 'Evidence that the butyrylcholinesterase K variant can protect against late-onset Alzheimer`s disease', Alzheimers Reports, 2, pp. 219 - 223

Mcritchie DA; Reid WG; Halliday GM; Hely MA; Brooks WS; Morris J, 1999, 'Neuropathology of three clinical cases prospectively diagnosed with diffuse Lewy body disease', Journal of Clinical Neuroscience, pp. 149 - 154

Taddei K; Yang D; Fisher C; Clarnette R; Hallmayer J; Barnetson R; Maller R; Brooks WS; Whyte S; Nicholson GA; Masters CL; Broe GA; Gandy SE; Martins RN, 1998, 'No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia', Neuroscience Letters, 246, pp. 178 - 180, http://dx.doi.org/10.1016/S0304-3940(98)00248-1

Taddei K; Kwok JB; Kril J; Halliday GM; Creasey H; Hallupp M; Fisher C; Brooks WS; Chung C; Andrews C; Masters C; Schofield PR; Martins RN, 1998, 'Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease.', Neuroreport, pp. 3335 - 3339

Cullen KM; Halliday GM; Double KL; Brooks WS; Creasey H; Broe GA, 1997, 'Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease', Neuroscience, 78, pp. 641 - 652, http://dx.doi.org/10.1016/S0306-4522(96)00569-6

Halliday GM; Brooks WS; Arthur HA; Creasey H; Broe T, 1997, 'Further evidence for an association between a mutation in the APP gene and Lewy body formation', Neuroscience Letters, pp. 49 - 52

Cullen K; Halliday GM; Double KL; Brooks WS; Creasey H; Broe T, 1997, 'Nucleus basalis cell loss is related to regional volumetric brain changes in Alzheimer's disease', Neuroscience, pp. 641 - 652

Kwok JB; Taddei K; Hallupp M; Fisher C; Brooks WS; Broe T; Hardy J; Fulham MJ; Nicholson GA; Stell R; St George-Hyslop PH; Fraser PE; Kakulas B; Clarnette R; Relkin N; Gandy SE; Schofield PR; Martins RN, 1997, 'Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer`s disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype', Neuroreport, pp. 1537 - 1542

Yang JG; Poropat RA; Brooks WS; Broe GA; Nicholson GA, 1996, 'Apolipoprotein E genotyping in Alzheimer's disease in an Australian sample', Australian and New Zealand Journal of Medicine, 26, pp. 658 - 661, http://dx.doi.org/10.1111/j.1445-5994.1996.tb02936.x

Hely MA; Reid WG; Halliday GM; Mcritchie DA; Leicester J; Joffe R; Brooks WS; Broe T; Morris J, 1996, 'Diffuse Lewy body disease: Clinical features in nine cases without co-existent Alzheimer's disease', Journal of Neurology Neurosurgery and Psychiatry, pp. 532 - 538

Harasty JA; Halliday GM; Code C; Brooks WS, 1996, 'Quantification of cortical atrophy in a case of progressive fluent asphsia', Brain, 119, pp. 181 - 190

Double KL; Halliday GM; Kril J; Harasty JA; Cullen K; Brooks WS; Creasey H; Broe T, 1996, 'Topography of brain atrophy during normal aging and Alzheimer's disease', Neurobiology of Aging, 17, pp. 513 - 521

Brooks WS; Martins RN; De Voecht J; Nicholson GA; Schofield PR; Kwok JBJ; Fisher C; Yeung LU; Van Broeckhoven C, 1995, 'A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with Alzheimer's disease', Neuroscience Letters, 199, pp. 183 - 186, http://dx.doi.org/10.1016/0304-3940(95)12046-7

Martins RN; Clarnette R; Fisher C; Broe GA; Brooks WS; Montgomery P; Gandy SE, 1995, 'ApoE genotypes in australia: Roles in early and late onset alzheimer’s disease and down’s syndrome', NeuroReport, 6, pp. 1513 - 1516, http://dx.doi.org/10.1097/00001756-199507310-00012

Maltby N; Broe GA; Creasey H; Jorm AF; Christensen H; Brooks WS, 1994, 'Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: Double blind trial', BMJ, 308, pp. 879, http://dx.doi.org/10.1136/bmj.308.6933.879

Martins RN; Muir J; Brooks WS; Creasey H; Montgomery P; Sellers P; Broe GA, 1993, 'Plasma amyloid precursor protein is decreased in alzheimer’s disease', NeuroReport, 4, pp. 757 - 759, http://dx.doi.org/10.1097/00001756-199306000-00040

Halliday GM; McCann HL; Pamphlett R; Brooks WS; Creasey H; McCusker E; Cotton RGH; Broe GA; Harper CG, 1992, 'Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation', Acta Neuropathologica, 84, pp. 638 - 650, http://dx.doi.org/10.1007/BF00227741

Back to profile page